These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 37156770)
1. Hepatic stellate cell stearoyl co-A desaturase activates leukotriene B4 receptor 2 - β-catenin cascade to promote liver tumorigenesis. Sinha S; Aizawa S; Nakano Y; Rialdi A; Choi HY; Shrestha R; Pan SQ; Chen Y; Li M; Kapelanski-Lamoureux A; Yochum G; Sher L; Monga SP; Lazaris A; Machida K; Karin M; Guccione E; Tsukamoto H Nat Commun; 2023 May; 14(1):2651. PubMed ID: 37156770 [TBL] [Abstract][Full Text] [Related]
2. Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6. Lai KKY; Kweon SM; Chi F; Hwang E; Kabe Y; Higashiyama R; Qin L; Yan R; Wu RP; Lai K; Fujii N; French S; Xu J; Wang JY; Murali R; Mishra L; Lee JS; Ntambi JM; Tsukamoto H Gastroenterology; 2017 May; 152(6):1477-1491. PubMed ID: 28143772 [TBL] [Abstract][Full Text] [Related]
3. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma. Xie YX; Liao R; Pan L; Du CY Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554 [TBL] [Abstract][Full Text] [Related]
4. TBX3 functions as a tumor suppressor downstream of activated CTNNB1 mutants during hepatocarcinogenesis. Liang B; Zhou Y; Qian M; Xu M; Wang J; Zhang Y; Song X; Wang H; Lin S; Ren C; Monga SP; Wang B; Evert M; Chen Y; Chen X; Huang Z; Calvisi DF; Chen X J Hepatol; 2021 Jul; 75(1):120-131. PubMed ID: 33577921 [TBL] [Abstract][Full Text] [Related]
5. AICAR and compound C negatively modulate HCC-induced primary human hepatic stellate cell activation in vitro. Böttcher K; Longato L; Marrone G; Mazza G; Ghemtio L; Hall A; Luong TV; Caruso S; Viollet B; Zucman-Rossi J; Pinzani M; Rombouts K Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G543-G556. PubMed ID: 33406006 [TBL] [Abstract][Full Text] [Related]
6. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation. Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529 [TBL] [Abstract][Full Text] [Related]
7. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma. Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681 [TBL] [Abstract][Full Text] [Related]
8. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features. Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431 [TBL] [Abstract][Full Text] [Related]
9. Hepatic stellate cells promote the progression of hepatocellular carcinoma through microRNA-1246-RORα-Wnt/β-Catenin axis. Huang JL; Fu YP; Gan W; Liu G; Zhou PY; Zhou C; Sun BY; Guan RY; Zhou J; Fan J; Yi Y; Qiu SJ Cancer Lett; 2020 Apr; 476():140-151. PubMed ID: 32061951 [TBL] [Abstract][Full Text] [Related]
11. Hepatic Stellate Cell Modulates the Immune Microenvironment in the Progression of Hepatocellular Carcinoma. Wang PW; Lin TY; Yang PM; Yeh CT; Pan TL Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142683 [TBL] [Abstract][Full Text] [Related]
12. Role of activated hepatic stellate cells in proliferation and metastasis of hepatocellular carcinoma. Lin N; Chen Z; Lu Y; Li Y; Hu K; Xu R Hepatol Res; 2015 Mar; 45(3):326-36. PubMed ID: 24827154 [TBL] [Abstract][Full Text] [Related]
13. Norepinephrine-stimulated HSCs secrete sFRP1 to promote HCC progression following chronic stress via augmentation of a Wnt16B/β-catenin positive feedback loop. Lin XH; Liu HH; Hsu SJ; Zhang R; Chen J; Chen J; Gao DM; Cui JF; Ren ZG; Chen RX J Exp Clin Cancer Res; 2020 Apr; 39(1):64. PubMed ID: 32293507 [TBL] [Abstract][Full Text] [Related]
14. Complete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model. Delgado E; Okabe H; Preziosi M; Russell JO; Alvarado TF; Oertel M; Nejak-Bowen KN; Zhang Y; Monga SP J Hepatol; 2015 Feb; 62(2):380-7. PubMed ID: 25457204 [TBL] [Abstract][Full Text] [Related]
15. Expression of NKG2D ligands is downregulated by β-catenin signalling and associates with HCC aggressiveness. Cadoux M; Caruso S; Pham S; Gougelet A; Pophillat C; Riou R; Loesch R; Colnot S; Nguyen CT; Calderaro J; Celton-Morizur S; Guerra N; Zucman-Rossi J; Desdouets C; Couty JP J Hepatol; 2021 Jun; 74(6):1386-1397. PubMed ID: 33484773 [TBL] [Abstract][Full Text] [Related]
16. Nuclear factor erythroid 2-related factor 2 and β-Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic Implications. Tao J; Krutsenko Y; Moghe A; Singh S; Poddar M; Bell A; Oertel M; Singhi AD; Geller D; Chen X; Lujambio A; Liu S; Monga SP Hepatology; 2021 Aug; 74(2):741-759. PubMed ID: 33529367 [TBL] [Abstract][Full Text] [Related]
17. Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin. Song J; Ge Z; Yang X; Luo Q; Wang C; You H; Ge T; Deng Y; Lin H; Cui Y; Chu W; Yao M; Zhang Z; Gu J; Fan J; Qin W Cancer Lett; 2015 Jan; 356(2 Pt B):713-20. PubMed ID: 25449435 [TBL] [Abstract][Full Text] [Related]